Recombinant Human IL-18 and Ofatumumab After PBSCT for Lymphoma

Clinical trial NCT01768338 · COMPLETED

Trial details

NCT number: NCT01768338
Sponsor: Michael John Robertson
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma

Start date: 2013-02-01
Primary completion: 2016-03-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.